Skip to main content

3 Result(s)

within James R. Lambert Remove this filter Life Sciences Remove this filter

and

  1. Article

    Open Access

    MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells

    Current treatment for patients with metastatic melanoma include molecular-targeted therapies and immune checkpoint inhibitors. However, a subset of melanomas are difficult-to-treat. These melanomas include tho...

    Nabanita Mukherjee, Jenette Skees, Kaleb J. Todd, Drake A. West… in Cell Death & Disease (2020)

    Download PDF (3238 KB) View Article

  2. Article

    Open Access

    Efficient identification of mutations that potentially confer treatment resistance through computational derivation

    Christy M Gearheart, James R Lambert, Christopher C Porter in BMC Bioinformatics (2015)

    Download PDF (219 KB) View Article

  3. No Access

    Protocol

    Analysis of Steroid Hormone-Induced Histone Acetylation by Chromatin Immunoprecipitation Assay

    Steroid hormone receptors are members of the nuclear receptor family of ligand-activated transcriptional regulatory proteins. Recent work in the field of nuclear receptor action has demonstrated an association...

    James R. Lambert, Steven K. Nordeen in Steroid Receptor Methods (2001)